Return to main site
Biblio
Found 1 results
Filters:
Keyword
is
Administration, Intravenous
[Clear All Filters]
2013
Kaminskas LM, Ascher DB, McLeod VM, Herold MJ, Le CP, Sloan EK, Porter CJH
. 2013.
PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases.
.
J Control Release. 168(2):200-8.
